Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.
about
Combination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production.Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.Antisense antimicrobial therapeuticsLactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.
P2860
Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@ast
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@en
type
label
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@ast
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@en
prefLabel
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@ast
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@en
P2093
P2860
P356
P1476
Use of pre-S protein-containin ...... c hepatitis B virus infection.
@en
P2093
Byung Cheol Ahn
Dong Yeon Kim
Hong Mo Moon
Hyo Sun Kim
Hyun Jin Jo
Jaeseung Yoon
John Morrey
Jung Sun Yum
Ki Hyun Kim
Young Chul Sung
P2860
P304
P356
10.1128/CVI.05355-11
P577
2011-12-07T00:00:00Z